Over the past 12 months, 9 insiders at Mirum Pharmaceuticals, Inc. filed 49 open-market SEC Form 4 transactions on MIRM: 1 purchase worth $9.0M and 48 sales worth $35.3M. Insiders have been net sellers over this period. The most recent filing was on Jul 6, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 6, 26 | Eric BjerkholtCHIEF FINANCIAL OFFICER | SELL | 3.1K | $124.94 | $380K |
| Jul 6, 26 | Christopher PeetzCHIEF EXECUTIVE OFFICER | SELL | 12.1K | $124.79 | $1.5M |
| Jul 1, 26 | Jolanda HoweSVP, GLOBAL CONTROLLER | SELL | 2.7K | $120.00 | $327K |
| Jun 17, 26 | Jolanda HoweSVP, GLOBAL CONTROLLER | SELL | 2.6K | $101.95 | $264K |
| Jun 8, 26 | Eric BjerkholtCHIEF FINANCIAL OFFICER | SELL | 2.3K | $95.12 | $210K |
| Jun 1, 26 | Saira Ramasastry | SELL | 4.0K | $100.00 | $398K |
| Mar 16, 26 | Saira RamasastryDirector | SELL | 2.0K | $90.76 | $182K |
| Mar 16, 26 | Eric BjerkholtCHIEF FINANCIAL OFFICER | SELL | 7.3K | $91.98 | $670K |
| Mar 16, 26 | Jolanda HoweSVP, GLOBAL CONTROLLER | SELL | 4.7K | $91.98 | $435K |
| Mar 16, 26 | Christopher PeetzCHIEF EXECUTIVE OFFICER | SELL | 41.0K | $91.98 | $3.8M |
| Mar 16, 26 | Joanne QuanCHIEF MEDICAL OFFICER | SELL | 7.3K | $91.98 | $670K |
| Mar 16, 26 | Peter RadovichPRESIDENT AND COO | SELL | 16.5K | $91.98 | $1.5M |
| Feb 13, 26 | Saira RamasastryDirector | SELL | 2.0K | $102.09 | $204K |
| Feb 2, 26 | Christopher PeetzCHIEF EXECUTIVE OFFICER | SELL | 9.1K | $103.30 | $941K |
| Feb 2, 26 | Peter RadovichPRESIDENT AND COO | SELL | 2.6K | $103.30 | $272K |
| Feb 2, 26 | Jolanda HoweSVP, GLOBAL CONTROLLER | SELL | 968 | $103.30 | $100K |
| Jan 26, 26 | Eric BjerkholtCHIEF FINANCIAL OFFICER | SELL | 1.1K | $96.19 | $101K |
| Jan 26, 26 | Jolanda HoweSVP, GLOBAL CONTROLLER | SELL | 842 | $96.19 | $81K |
| Jan 26, 26 | Christopher PeetzCHIEF EXECUTIVE OFFICER | SELL | 6.8K | $96.19 | $657K |
| Jan 26, 26 | Peter RadovichPRESIDENT AND COO | SELL | 3.1K | $96.19 | $302K |
| Jan 23, 26 | Patrick J HeronDirector | BUY | 131.4K | $68.48 | $9.0M |
| Jan 22, 26 | Eric BjerkholtCHIEF FINANCIAL OFFICER | SELL | 1.4K | $93.33 | $133K |
| Jan 22, 26 | Jolanda HoweSVP, GLOBAL CONTROLLER | SELL | 926 | $93.33 | $86K |
| Jan 22, 26 | Christopher PeetzCHIEF EXECUTIVE OFFICER | SELL | 7.1K | $93.33 | $662K |
| Jan 22, 26 | Joanne QuanCHIEF MEDICAL OFFICER | SELL | 1.8K | $93.33 | $170K |
| Jan 22, 26 | Peter RadovichPRESIDENT AND COO | SELL | 2.4K | $93.33 | $222K |
| Jan 20, 26 | Joanne QuanCHIEF MEDICAL OFFICER | SELL | 6.9K | $90.27 | $624K |
| Jan 15, 26 | Saira RamasastryDirector | SELL | 2.0K | $90.99 | $182K |
| Dec 22, 25 | Saira RamasastryDirector | SELL | 5.0K | $80.00 | $400K |
| Dec 19, 25 | Michael G GreyDirector | SELL | 50.0K | $78.00 | $3.9M |
| Dec 18, 25 | Saira RamasastryDirector | SELL | 1.0K | $69.46 | $69K |
| Dec 1, 25 | Michael G GreyDirector | SELL | 50.0K | $74.00 | $3.7M |
| Nov 21, 25 | Michael G GreyDirector | SELL | 50.0K | $70.00 | $3.5M |
| Sep 12, 25 | Eric BjerkholtCHIEF FINANCIAL OFFICER | SELL | 9.6K | $76.01 | $728K |
| Sep 11, 25 | Laura BregeDirector | SELL | 15.5K | $75.07 | $1.2M |
| Sep 8, 25 | Saira RamasastryDirector | SELL | 17.0K | - | $0 |
| Aug 11, 25 | Eric BjerkholtCHIEF FINANCIAL OFFICER | SELL | 8.0K | - | $0 |
| Aug 11, 25 | Christopher PeetzCHIEF EXECUTIVE OFFICER | SELL | 40.0K | $62.00 | $2.5M |
| Aug 7, 25 | Jolanda HoweSVP, GLOBAL CONTROLLER | SELL | 10.0K | $58.00 | $580K |
| Aug 7, 25 | Christopher PeetzCHIEF EXECUTIVE OFFICER | SELL | 40.0K | $55.25 | $2.2M |
| Jul 3, 25 | Jolanda HoweSVP, GLOBAL CONTROLLER | SELL | 477 | $49.08 | $23K |
| Jul 2, 25 | Jolanda HoweSVP, GLOBAL CONTROLLER | SELL | 564 | $48.25 | $27K |
| Jun 11, 25 | William FaireyDirector | SELL | 3.2K | $48.42 | $155K |
| Jun 3, 25 | Saira RamasastryDirector | SELL | 2.5K | $45.74 | $114K |
| Jun 2, 25 | Saira RamasastryDirector | SELL | 5.7K | $46.20 | $263K |
| Mar 18, 25 | Jolanda HoweSVP, GLOBAL CONTROLLER | SELL | 2.4K | $44.45 | $107K |
| Mar 17, 25 | Jolanda HoweSVP, GLOBAL CONTROLLER | SELL | 50.1K | $44.75 | $2.2M |
| Mar 17, 25 | Christopher PeetzCHIEF EXECUTIVE OFFICER | SELL | 27.3K | $44.21 | $1.2M |
| Mar 17, 25 | Peter RadovichPRESIDENT AND COO | SELL | 7.9K | $44.21 | $348K |
| Mar 17, 25 | Patrick J HeronDirector | BUY | 21 | $43.93 | $923 |
Over the past 12 months, insiders at Mirum Pharmaceuticals, Inc. filed 1 open-market purchase worth $9.0M and 48 sales worth $35.3M on MIRM, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 6, 26.
The largest recent open-market MIRM insider purchase in our data was $9.0M by Patrick J Heron, Director, filed on Jan 23, 26.
9 different insiders at Mirum Pharmaceuticals, Inc. filed open-market SEC Form 4 transactions on MIRM over the last 12 months.
InsiderTape plots every MIRM insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Mirum Pharmaceuticals, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →